Patents by Inventor Kathleen Stringer

Kathleen Stringer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10330685
    Abstract: Provided herein is technology relating to treatment of sepsis and particularly, but not exclusively, to methods for predicting a response of a sepsis patient to treatment with L-carnitine.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: June 25, 2019
    Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
    Inventors: Kathleen Stringer, Alan E. Jones, Mike Puskarich
  • Publication number: 20170052192
    Abstract: Provided herein is technology relating to treatment of sepsis and particularly, but not exclusively, to methods for predicting a response of a sepsis patient to treatment with L-carnitine.
    Type: Application
    Filed: April 28, 2015
    Publication date: February 23, 2017
    Inventors: Kathleen STRINGER, Alan E. JONES, Mike PUSKARICH
  • Publication number: 20160220710
    Abstract: Provided herein are microcrystalline forms of drugs. In particular, provided herein are microcrystalline drug formulations for delivery to macrophages and treatment of disease.
    Type: Application
    Filed: January 29, 2016
    Publication date: August 4, 2016
    Inventors: Rahul K. Keswani, Gi S. Yoon, Kathleen Stringer, Gustavo Rosania, Chao Tian, Xueding Wang